Today’s Form D Alert: Carogen Corporaton $3.08 million Financing. Bijan Almassian Released Oct 11 form

Biotechnology Carogen Corporaton - Bijan Almassian

Carogen Corporaton Financing

Carogen Corporaton, Corporation just submitted form D regarding $3.08 million equity financing. This is a new filing. Carogen Corporaton was able to sell $2.08 million so far. That is 67.51% of the offering. The total fundraising amount was $3.08 million. The financing form was filed on 2016-10-11. The reason for the financing was: unspecified. The fundraising still has about $1.00 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Carogen Corporaton is based in Connecticut. The filler’s business is Biotechnology. The SEC form was signed by Bijan Almassian President and Chief Executive Officer. The company was incorporated in 2012. The filler’s address is: Cell & Genome Sciences Building, 400 Farmington Avenue, Room 2802, Farmington, Ct, Connecticut, 06036. Bijan Almassian is the related person in the form and it has address: Cell & Genome Sciences Building, 400 Farmington Avenue, Room 2802, Farmington, Ct, Connecticut, 06036. Link to Carogen Corporaton Filing: 000168704216000001.

Analysis of Carogen Corporaton Offering

On average, companies in the Biotechnology sector, sell 73.77% of the total offering amount. Carogen Corporaton sold 67.51% of the offering. The fundraising is still open. The average fundraising size for companies in the Biotechnology industry is $3.08 million. The offering was 32.46% smaller than the average of $3.08 million. Of course this should not be seen as negative. Firms get financed for different needs and reasons. The minimum investment for this fundraising is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Carogen Corporaton Also

The Form D signed by Bijan Almassian might help Carogen Corporaton’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment